open federal funding opportunity
DoW Amyotrophic Lateral Sclerosis Research Program, Therapeutic Idea Award
Summary: The fiscal year 2026 (FY26) Amyotrophic Lateral Sclerosis Research Program (ALSRP) Therapeutic Idea Award (TIA) supports new, innovative, high-risk, high-gain ideas aimed at amyotrophic lateral sclerosis (ALS) drug or therapy discovery. The studies supported by this award mechanism are expected to be hypoth…
- Agency
- Defense Health Agency Contracting Activity - DHACA
- Opportunity number
- HT942526ALSRPTIA